Major [**First Name3 (LF) 2947**] or Invasive Procedure: [**2124-1-25**]: Exploratory laparotomy with open pancreatic biopsy, cholecystectomy, fiducial placement, gastrojejunostomy and Roux-en-Y hepaticojejunostomy.
He was managed there with an ERCP performed by Dr. [**Last Name (STitle) **], which demonstrated a large mass at the major papilla with a stricture the lower through the common bile duct, obviously concerning for malignancy.
PSHx: (R) knee arthroscopy, umbilical hernia repair [**2119**]  Social History: Lives alone, son lives in RI, son and sister are HCP.
His abdomen is scaphoid with a well-healed umbilical incision from his umbilical hernia repair of several years ago.
Pertinent Results: On Admission:  [**2124-1-24**] 12:10PM   WBC-8.2# RBC-4.27* HGB-13.4* HCT-40.6 MCV-95 MCH-31.4 MCHC-33.0 RDW-16.3* [**2124-1-24**] 12:10PM   ALT(SGPT)-106* AST(SGOT)-133* ALK PHOS-430* AMYLASE-70 TOT BILI-4.2* [**2124-1-24**] 12:10PM   GLUCOSE-106* UREA N-11 CREAT-0.7 SODIUM-132* POTASSIUM-4.2 CHLORIDE-96 TOTAL CO2-26 ANION GAP-14 [**2124-1-24**] 01:40PM   PT-11.5 PTT-30.8 INR(PT)-1.0 [**2124-1-24**] 03:00PM URINE  RBC-1 WBC-2 BACTERIA-NONE YEAST-NONE EPI-1 [**2124-1-24**] 03:00PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-30 GLUCOSE-NEG KETONE-NEG BILIRUBIN-SM  UROBILNGN-4* PH-5.5 LEUK-NEG [**2124-1-24**] 03:00PM URINE  COLOR-DkAmb APPEAR-Hazy SP [**Last Name (un) 155**]-1.024 [**2124-1-25**] 09:45AM   freeCa-1.10* [**2124-1-25**] 10:50PM   GLUCOSE-129* LACTATE-2.0 NA+-133* K+-3.8 CL--104 [**2124-1-25**] 10:50PM   freeCa-1.06* [**2124-1-25**] 03:21PM   GLUCOSE-133* UREA N-14 CREAT-0.7 SODIUM-135 POTASSIUM-5.3* CHLORIDE-103 TOTAL CO2-26 ANION GAP-11 [**2124-1-25**] 03:21PM   WBC-11.7* RBC-3.89* HGB-12.4* HCT-36.8* MCV-95 MCH-31.9 MCHC-33.7 RDW-15.9* [**2124-1-25**] 03:21PM   PLT COUNT-380 [**2124-1-25**] 03:21PM   PT-12.0 INR(PT)-1.0 [**2124-1-25**] 12:46PM   GLUCOSE-123* LACTATE-1.2 NA+-134* K+-4.4 CL--101 [**2124-1-25**] 12:46PM   HGB-12.1* calcHCT-36 [**2124-1-25**] 12:46PM   freeCa-1.10* .
[**2124-1-25**] AP CXR: ET tube in standard placement.
Right jugular line tip projects over the mid SVC.
Nasogastric tube passes into the stomach and out of view.
NG tube tip is in the stomach.
A right IJ catheter tip is in the SVC.
Brief Hospital Course: The patient was admitted to the General [**Month/Day/Year 2947**] Service on [**2124-1-25**] for evaluation and treatment of periampullary adenocarcinoma.
On this date, the patient underwent exploratory laparotomy with open pancreatic biopsy, cholecystectomy, fiducial placement, gastrojejunostomy and Roux-en-Y hepaticojejunostomy for an intra-operative finding of ampullary cancer metastatic to common hepatic arterial lymph node, which went well without complication (reader referred to the Operative Note for details).
The patient was transferred to the SICU in stable condition NPO with an NG tube, on IV fluids, with a foley catheter in place, and a Dilaudid/Bupivacaine epidural for pain control.
Later, Fentanyl IV was added to the pain control regimen due to ineffective pain control.
Due to the findings on re-intubation CXR, Intervention Pulmonology was consulted.
Neuro: As above, the patient ultimately received a Bupivacaine epidural with Fentanyl IV post-operatively with good effect and adequate pain control.
Prior to transfer to the inpatient floor, the Bupivacaine epidural and Fentanyl were discontinued, and the patient wasgiven Morphine IV PRN with continued good pain control.
When tolerating oral intake, the patient was transitioned to oral pain medications.
After extubation, patient required Albuterol and Atrovent Nebulizer treatments, aggressive respiratory toilet, and his Symbicort MDI was initiated.
Waened off supplemental oxygen on [**2124-1-29**].
GI/GU/FEN: Post-operatively, the patient was made NPO on IV fluids.
He required multiple IV fluid boluses for low urine output and tachycardia with good response.
After his NG tube was discontinued on [**2124-1-28**], he was started on sips of clears.
Foley catheter was discontinued on [**2124-1-28**]; he was usbsequently able to void without problem.
Prophylaxis: The patient received subcutaneous heparin and venodyne boots were used during this stay; was encouraged to get up and ambulate as early as possible.
Symbicort 160-4.5 mcg/Actuation HFA Aerosol Inhaler Sig: One (1) Inhalation [**Hospital1 **] 2.
Aspirin 81 mg Tablet Sig: One (1) Tablet PO once a day.
Acetaminophen 325 mg Tablet Sig: 1-2 Tablets PO every six (6) hours as needed for pain for 2 weeks.
Oxycodone 5 mg Tablet Sig: One (1) Tablet PO every 4-6 hours as needed for pain.
Aspirin 81 mg Tablet Sig: One (1) Tablet PO once a day.
Symbicort 160-4.5 mcg/Actuation HFA Aerosol Inhaler Sig: One (1)  Inhalation 1 inhalation [**Hospital1 **] ().
Metoclopramide 10 mg Tablet Sig: One (1) Tablet PO QID (4 times a day).
Pantoprazole 40 mg Tablet, Delayed Release (E.C.)
Colace 100 mg Capsule Sig: One (1) Capsule PO twice a day as needed for constipation.
Senna 8.6 mg Tablet Sig: One (1) Tablet PO twice a day as needed for constipation: Over-the-counter.
Albuterol Sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: Two (2) puffs Inhalation four times a day as needed for shortness of breath or wheezing.
COPD   Discharge Condition: Mental Status:Clear and coherent Level of Consciousness:Alert and interactive Activity Status:Ambulatory - Independent   Discharge Instructions: *You experience new chest pain, pressure, squeezing or tightness.
Please resume all regular home medications , unless specifically advised not to take a particular medication.
Also, please take any new medications as prescribed.
Avoid driving or operating heavy machinery while taking pain medications.
